Rise and shine, everyone, another busy day is on the way. This morning is getting off to a fabulous start, though, as a delightfully warm sun is enveloping the subdued Pharmalot campus, since the official mascot was taken for his morning constitutional. This means we can quaff our next cup of stimulation in peace. Our choice today is golden French toast, for those who track this sort of thing. Meanwhile, here is the latest menu of tidbits for your reading pleasure. So, time to get cracking. Hope you have a smashing day and do stay in touch. We always enjoy your tips and insights. …
The World Health Organization plans to broadly roll out a much-needed malaria vaccine, saying pilot testing had shown that it was safe and could be effectively deployed in remote and rural settings, STAT says. The decision marks a landmark moment in the fight against malaria, for which no other vaccines exist. The disease killed roughly 400,000 people in 2019 — the most recent year for which statistics are available — mostly in sub-Saharan Africa. The biggest toll is on young children; an estimated 279,000 children under the age of 5 died from malaria in 2019. The vaccine, known as RTS,S, was developed by GlaxoSmithKline (GSK) and is given in four doses.
Pfizer (PFE) and BioNTech (BNTX) have asked the U.S. Food and Drug Administration to endorse their Covid-19 vaccine for children 5 to 11 years old, setting up the shot to potentially be available to millions of youngsters in a matter of weeks, The Wall Street Journal notes. The FDA may clear the shot for use in the youths before November, which would mean pediatrician offices, schools, and other locations could get doses to give as early as Halloween. The FDA has already scheduled for a panel of outside experts to review the data Oct. 26. School districts and public-health officials have begun preparations for vaccinations, though the work remains in early stages.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
